Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 9 | 2022 | 264 | 3.270 |
Why?
|
| Receptors, Dopamine D2 | 8 | 2019 | 80 | 3.050 |
Why?
|
| Amphetamine | 12 | 2022 | 36 | 2.370 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 12 | 2022 | 96 | 2.310 |
Why?
|
| Dopamine | 15 | 2022 | 226 | 2.180 |
Why?
|
| Dopamine Uptake Inhibitors | 6 | 2018 | 120 | 1.400 |
Why?
|
| RGS Proteins | 3 | 2017 | 18 | 1.270 |
Why?
|
| Ethanol | 3 | 2019 | 185 | 1.220 |
Why?
|
| Animals | 38 | 2022 | 7297 | 1.100 |
Why?
|
| Rats | 18 | 2020 | 1604 | 1.000 |
Why?
|
| Nucleus Accumbens | 5 | 2018 | 92 | 0.980 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2019 | 747 | 0.940 |
Why?
|
| Receptors, Opioid | 2 | 2022 | 38 | 0.940 |
Why?
|
| Autoreceptors | 2 | 2014 | 9 | 0.940 |
Why?
|
| Central Nervous System Stimulants | 3 | 2015 | 74 | 0.840 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 113 | 0.810 |
Why?
|
| Ventral Tegmental Area | 2 | 2019 | 31 | 0.800 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 126 | 0.800 |
Why?
|
| Protein Kinase C | 2 | 2013 | 37 | 0.790 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2019 | 4 | 0.710 |
Why?
|
| Endocytosis | 1 | 2019 | 11 | 0.710 |
Why?
|
| Ubiquitination | 1 | 2019 | 14 | 0.710 |
Why?
|
| Receptors, Dopamine D3 | 2 | 2015 | 33 | 0.650 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2017 | 7 | 0.620 |
Why?
|
| Brain | 5 | 2015 | 930 | 0.590 |
Why?
|
| Motor Activity | 6 | 2015 | 310 | 0.570 |
Why?
|
| Behavior, Animal | 6 | 2016 | 264 | 0.560 |
Why?
|
| Mice | 17 | 2016 | 2368 | 0.550 |
Why?
|
| Prefrontal Cortex | 4 | 2020 | 69 | 0.540 |
Why?
|
| Cell Membrane | 6 | 2019 | 97 | 0.520 |
Why?
|
| Synaptic Vesicles | 2 | 2003 | 7 | 0.480 |
Why?
|
| Self Administration | 5 | 2018 | 296 | 0.440 |
Why?
|
| Male | 22 | 2019 | 17807 | 0.370 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 680 | 0.370 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2014 | 22 | 0.360 |
Why?
|
| Signal Transduction | 4 | 2018 | 666 | 0.360 |
Why?
|
| Corpus Striatum | 3 | 2015 | 60 | 0.350 |
Why?
|
| Benzothiepins | 1 | 2008 | 1 | 0.340 |
Why?
|
| Sulfonamides | 1 | 2008 | 65 | 0.330 |
Why?
|
| Neostriatum | 1 | 2007 | 21 | 0.300 |
Why?
|
| Stereotyped Behavior | 2 | 2003 | 14 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2018 | 641 | 0.300 |
Why?
|
| Reward | 2 | 2010 | 63 | 0.290 |
Why?
|
| Disulfides | 1 | 2006 | 34 | 0.290 |
Why?
|
| Stress, Psychological | 1 | 2008 | 208 | 0.290 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 38 | 0.280 |
Why?
|
| Mutation | 2 | 2006 | 466 | 0.280 |
Why?
|
| Moths | 1 | 2005 | 2 | 0.280 |
Why?
|
| Cysteine | 1 | 2006 | 131 | 0.270 |
Why?
|
| Mice, Knockout | 5 | 2015 | 425 | 0.270 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 34 | 0.270 |
Why?
|
| Methylphenidate | 1 | 2005 | 36 | 0.260 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 97 | 0.260 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 2 | 2016 | 4 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 711 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 118 | 0.250 |
Why?
|
| RNA, Messenger | 2 | 2017 | 514 | 0.250 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 109 | 0.250 |
Why?
|
| Phosphotransferases | 1 | 2003 | 5 | 0.240 |
Why?
|
| Glutamate Decarboxylase | 1 | 2003 | 17 | 0.240 |
Why?
|
| Isoenzymes | 1 | 2003 | 63 | 0.240 |
Why?
|
| Testosterone | 1 | 2003 | 47 | 0.230 |
Why?
|
| Cyclic AMP | 2 | 2016 | 40 | 0.230 |
Why?
|
| Conditioning, Operant | 4 | 2015 | 96 | 0.230 |
Why?
|
| Parkinsonian Disorders | 1 | 2002 | 9 | 0.220 |
Why?
|
| Basal Ganglia | 1 | 2002 | 15 | 0.220 |
Why?
|
| Brain Chemistry | 1 | 2002 | 30 | 0.220 |
Why?
|
| Feeding Behavior | 4 | 2009 | 159 | 0.210 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 98 | 0.210 |
Why?
|
| Transcription Factors | 1 | 2022 | 172 | 0.200 |
Why?
|
| Cholesterol | 1 | 2022 | 229 | 0.200 |
Why?
|
| Biological Transport | 3 | 2006 | 62 | 0.200 |
Why?
|
| Phosphorylation | 2 | 2016 | 225 | 0.190 |
Why?
|
| Enkephalins | 1 | 2020 | 9 | 0.190 |
Why?
|
| Cell Line | 4 | 2016 | 449 | 0.190 |
Why?
|
| Putamen | 1 | 2020 | 25 | 0.190 |
Why?
|
| Schizosaccharomyces | 1 | 2020 | 3 | 0.190 |
Why?
|
| Histone Demethylases | 1 | 2020 | 8 | 0.190 |
Why?
|
| Heterochromatin | 1 | 2020 | 11 | 0.190 |
Why?
|
| Opioid Peptides | 1 | 2020 | 28 | 0.190 |
Why?
|
| Analysis of Variance | 3 | 2015 | 454 | 0.180 |
Why?
|
| Receptors, Opioid, mu | 1 | 2020 | 51 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 8 | 0.180 |
Why?
|
| RNA Interference | 1 | 2019 | 76 | 0.170 |
Why?
|
| Psychomotor Performance | 3 | 2009 | 97 | 0.170 |
Why?
|
| Protein Transport | 3 | 2016 | 74 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2016 | 36 | 0.170 |
Why?
|
| Receptors, Vasopressin | 1 | 2018 | 7 | 0.170 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 8 | 0.170 |
Why?
|
| Kidney | 2 | 2015 | 485 | 0.160 |
Why?
|
| Tritium | 3 | 2015 | 17 | 0.160 |
Why?
|
| Spinal Nerves | 1 | 2018 | 65 | 0.160 |
Why?
|
| Drug Tolerance | 1 | 2017 | 36 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 2017 | 24 | 0.150 |
Why?
|
| Protein Isoforms | 1 | 2017 | 56 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2018 | 190 | 0.150 |
Why?
|
| Myocardium | 2 | 2015 | 170 | 0.150 |
Why?
|
| Clathrin | 1 | 2016 | 3 | 0.150 |
Why?
|
| Endosomes | 1 | 2016 | 13 | 0.150 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2016 | 24 | 0.140 |
Why?
|
| Cocaine-Related Disorders | 1 | 2017 | 106 | 0.140 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2016 | 8 | 0.140 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2016 | 51 | 0.140 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2016 | 40 | 0.140 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2016 | 53 | 0.140 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 280 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2016 | 131 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 350 | 0.140 |
Why?
|
| Ketamine | 1 | 2015 | 20 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2015 | 106 | 0.130 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 113 | 0.130 |
Why?
|
| Presynaptic Terminals | 1 | 2015 | 36 | 0.130 |
Why?
|
| Neurons | 2 | 2010 | 394 | 0.130 |
Why?
|
| Extracellular Space | 1 | 2014 | 25 | 0.120 |
Why?
|
| Heart | 1 | 2015 | 161 | 0.120 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 43 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2013 | 799 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 244 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 481 | 0.110 |
Why?
|
| Synaptosomes | 2 | 2015 | 17 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 12 | 0.110 |
Why?
|
| Microdialysis | 2 | 2014 | 33 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 980 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 249 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2014 | 281 | 0.090 |
Why?
|
| Leptin | 1 | 2010 | 66 | 0.090 |
Why?
|
| Feedback, Psychological | 1 | 2009 | 5 | 0.090 |
Why?
|
| Reinforcement Schedule | 1 | 2009 | 60 | 0.090 |
Why?
|
| Microscopy, Interference | 1 | 2009 | 2 | 0.090 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2008 | 1 | 0.090 |
Why?
|
| Motivation | 1 | 2009 | 102 | 0.080 |
Why?
|
| Humans | 4 | 2016 | 29093 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 73 | 0.080 |
Why?
|
| Receptors, Presynaptic | 1 | 2007 | 1 | 0.080 |
Why?
|
| Biotin | 1 | 2007 | 7 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2002 | 494 | 0.080 |
Why?
|
| Telemetry | 1 | 2007 | 27 | 0.080 |
Why?
|
| Dithiothreitol | 1 | 2006 | 8 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2006 | 13 | 0.070 |
Why?
|
| Calcium | 1 | 2008 | 296 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 82 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2006 | 17 | 0.070 |
Why?
|
| Kinetics | 1 | 2006 | 205 | 0.070 |
Why?
|
| Heart Failure | 1 | 2012 | 568 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 76 | 0.070 |
Why?
|
| Artifacts | 1 | 2006 | 38 | 0.070 |
Why?
|
| Coca | 1 | 2005 | 1 | 0.070 |
Why?
|
| Larva | 1 | 2005 | 4 | 0.070 |
Why?
|
| Plant Leaves | 1 | 2005 | 4 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 172 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 74 | 0.070 |
Why?
|
| Harmaline | 2 | 2002 | 2 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2005 | 36 | 0.070 |
Why?
|
| Phenylalanine | 1 | 2005 | 5 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2005 | 32 | 0.070 |
Why?
|
| Radioligand Assay | 1 | 2005 | 23 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 40 | 0.070 |
Why?
|
| Haplorhini | 1 | 2005 | 64 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 95 | 0.070 |
Why?
|
| Tongue | 2 | 2002 | 13 | 0.070 |
Why?
|
| Hand Strength | 2 | 2002 | 85 | 0.070 |
Why?
|
| Stereotypic Movement Disorder | 2 | 2003 | 2 | 0.070 |
Why?
|
| Locomotion | 2 | 2003 | 31 | 0.060 |
Why?
|
| Transfection | 1 | 2005 | 192 | 0.060 |
Why?
|
| Genetics, Behavioral | 1 | 2004 | 2 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2015 | 102 | 0.060 |
Why?
|
| Food | 1 | 2004 | 41 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2003 | 12 | 0.060 |
Why?
|
| Scintillation Counting | 1 | 2003 | 2 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 11 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2003 | 30 | 0.060 |
Why?
|
| Carbon Radioisotopes | 1 | 2003 | 20 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 51 | 0.060 |
Why?
|
| Head Movements | 1 | 2003 | 13 | 0.060 |
Why?
|
| Swine | 1 | 2003 | 201 | 0.060 |
Why?
|
| Time Factors | 3 | 2015 | 2001 | 0.060 |
Why?
|
| Neurotrophin 3 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2002 | 39 | 0.050 |
Why?
|
| Consummatory Behavior | 1 | 2001 | 2 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2001 | 16 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2002 | 183 | 0.050 |
Why?
|
| Pyridines | 1 | 2001 | 78 | 0.050 |
Why?
|
| Rodentia | 1 | 2001 | 10 | 0.050 |
Why?
|
| Neurophysiology | 1 | 2001 | 9 | 0.050 |
Why?
|
| Tremor | 1 | 2001 | 11 | 0.050 |
Why?
|
| Postural Balance | 1 | 2002 | 160 | 0.050 |
Why?
|
| Lentivirus | 1 | 2019 | 11 | 0.050 |
Why?
|
| Amygdala | 1 | 2019 | 60 | 0.040 |
Why?
|
| Female | 3 | 2018 | 18164 | 0.040 |
Why?
|
| Ligation | 1 | 2018 | 55 | 0.040 |
Why?
|
| Glucose | 1 | 2019 | 163 | 0.040 |
Why?
|
| Oxytocin | 1 | 2018 | 22 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2018 | 124 | 0.040 |
Why?
|
| Hippocampus | 1 | 2019 | 185 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2018 | 88 | 0.040 |
Why?
|
| Benzoxazines | 1 | 2016 | 20 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2016 | 34 | 0.040 |
Why?
|
| Cyclohexanols | 1 | 2016 | 20 | 0.040 |
Why?
|
| Morpholines | 1 | 2016 | 34 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2016 | 39 | 0.040 |
Why?
|
| Reaction Time | 2 | 2009 | 121 | 0.040 |
Why?
|
| Compulsive Behavior | 1 | 2016 | 4 | 0.040 |
Why?
|
| Endocannabinoids | 1 | 2016 | 34 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2016 | 64 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 72 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 174 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 50 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 125 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 45 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 2015 | 6 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 9 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 85 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2015 | 19 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 196 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 159 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 199 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 93 | 0.030 |
Why?
|
| Analgesics | 1 | 2015 | 126 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 162 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 519 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 239 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 337 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 160 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2012 | 13 | 0.030 |
Why?
|
| Catecholamines | 1 | 2012 | 17 | 0.030 |
Why?
|
| Fibrosis | 1 | 2012 | 102 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2012 | 103 | 0.030 |
Why?
|
| Appetite Regulation | 1 | 2010 | 2 | 0.020 |
Why?
|
| Appetite | 1 | 2010 | 19 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 573 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 81 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 51 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 87 | 0.020 |
Why?
|
| DNA | 1 | 2006 | 204 | 0.020 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2004 | 2 | 0.020 |
Why?
|
| Species Specificity | 1 | 2004 | 84 | 0.020 |
Why?
|
| Genotype | 1 | 2006 | 735 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 246 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2002 | 2 | 0.010 |
Why?
|
| Proprioception | 1 | 2002 | 5 | 0.010 |
Why?
|
| Muscle Spindles | 1 | 2002 | 4 | 0.010 |
Why?
|
| Hyperkinesis | 1 | 2002 | 6 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 2002 | 23 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 2002 | 20 | 0.010 |
Why?
|
| Motor Skills | 1 | 2001 | 12 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2003 | 364 | 0.010 |
Why?
|
| Oxidopamine | 1 | 2001 | 6 | 0.010 |
Why?
|
| Space Perception | 1 | 2001 | 26 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2001 | 29 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2001 | 33 | 0.010 |
Why?
|